0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Quadrivalent Flu Vaccine Sales Market Report 2021
Published Date: June 2021
|
Report Code: QYRE-Auto-21C5159
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Quadrivalent Flu Vaccine Sales Market Report 2021

Global Quadrivalent Flu Vaccine Sales Market Report 2021

Code: QYRE-Auto-21C5159
Report
June 2021
139 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
The global Quadrivalent Flu Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Quadrivalent Flu Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

Intramuscular Injection
Nasal Spray
Intradermal Shot

Segment by Application

Hospital
Clinic
Public Health Agency
Other
The Quadrivalent Flu Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Quadrivalent Flu Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

BY COMPANY

Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
1 Quadrivalent Flu Vaccine Market Overview
1.1 Quadrivalent Flu Vaccine Product Scope
1.2 Quadrivalent Flu Vaccine Segment by Type
1.2.1 Global Quadrivalent Flu Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Quadrivalent Flu Vaccine Segment by Application
1.3.1 Global Quadrivalent Flu Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Quadrivalent Flu Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Quadrivalent Flu Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Quadrivalent Flu Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Quadrivalent Flu Vaccine Price Trends (2016-2027)
2 Quadrivalent Flu Vaccine Estimates and Forecasts by Region
2.1 Global Quadrivalent Flu Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Quadrivalent Flu Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Quadrivalent Flu Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Quadrivalent Flu Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Quadrivalent Flu Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Quadrivalent Flu Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Quadrivalent Flu Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Quadrivalent Flu Vaccine Estimates and Projections (2016-2027)
2.4.3 China Quadrivalent Flu Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Quadrivalent Flu Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Quadrivalent Flu Vaccine Estimates and Projections (2016-2027)
2.4.6 India Quadrivalent Flu Vaccine Estimates and Projections (2016-2027)
3 Global Quadrivalent Flu Vaccine Competition Landscape by Players
3.1 Global Top Quadrivalent Flu Vaccine Players by Sales (2016-2021)
3.2 Global Top Quadrivalent Flu Vaccine Players by Revenue (2016-2021)
3.3 Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Quadrivalent Flu Vaccine as of 2020)
3.4 Global Quadrivalent Flu Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Quadrivalent Flu Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Quadrivalent Flu Vaccine Market Size by Type
4.1 Global Quadrivalent Flu Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Quadrivalent Flu Vaccine Price by Type (2016-2021)
4.2 Global Quadrivalent Flu Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Quadrivalent Flu Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Quadrivalent Flu Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Quadrivalent Flu Vaccine Price Forecast by Type (2022-2027)
5 Global Quadrivalent Flu Vaccine Market Size by Application
5.1 Global Quadrivalent Flu Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Quadrivalent Flu Vaccine Price by Application (2016-2021)
5.2 Global Quadrivalent Flu Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Quadrivalent Flu Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Quadrivalent Flu Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Quadrivalent Flu Vaccine Price Forecast by Application (2022-2027)
6 North America Quadrivalent Flu Vaccine Market Facts & Figures
6.1 North America Quadrivalent Flu Vaccine Sales by Company
6.1.1 North America Quadrivalent Flu Vaccine Sales by Company (2016-2021)
6.1.2 North America Quadrivalent Flu Vaccine Revenue by Company (2016-2021)
6.2 North America Quadrivalent Flu Vaccine Sales Breakdown by Type
6.2.1 North America Quadrivalent Flu Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Quadrivalent Flu Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Quadrivalent Flu Vaccine Sales Breakdown by Application
6.3.1 North America Quadrivalent Flu Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Quadrivalent Flu Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Quadrivalent Flu Vaccine Market Facts & Figures
7.1 Europe Quadrivalent Flu Vaccine Sales by Company
7.1.1 Europe Quadrivalent Flu Vaccine Sales by Company (2016-2021)
7.1.2 Europe Quadrivalent Flu Vaccine Revenue by Company (2016-2021)
7.2 Europe Quadrivalent Flu Vaccine Sales Breakdown by Type
7.2.1 Europe Quadrivalent Flu Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Quadrivalent Flu Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Quadrivalent Flu Vaccine Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Quadrivalent Flu Vaccine Market Facts & Figures
8.1 China Quadrivalent Flu Vaccine Sales by Company
8.1.1 China Quadrivalent Flu Vaccine Sales by Company (2016-2021)
8.1.2 China Quadrivalent Flu Vaccine Revenue by Company (2016-2021)
8.2 China Quadrivalent Flu Vaccine Sales Breakdown by Type
8.2.1 China Quadrivalent Flu Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Quadrivalent Flu Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Quadrivalent Flu Vaccine Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)
9 Japan Quadrivalent Flu Vaccine Market Facts & Figures
9.1 Japan Quadrivalent Flu Vaccine Sales by Company
9.1.1 Japan Quadrivalent Flu Vaccine Sales by Company (2016-2021)
9.1.2 Japan Quadrivalent Flu Vaccine Revenue by Company (2016-2021)
9.2 Japan Quadrivalent Flu Vaccine Sales Breakdown by Type
9.2.1 Japan Quadrivalent Flu Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Quadrivalent Flu Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Quadrivalent Flu Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Quadrivalent Flu Vaccine Market Facts & Figures
10.1 Southeast Asia Quadrivalent Flu Vaccine Sales by Company
10.1.1 Southeast Asia Quadrivalent Flu Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Quadrivalent Flu Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Quadrivalent Flu Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Quadrivalent Flu Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Quadrivalent Flu Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Quadrivalent Flu Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India Quadrivalent Flu Vaccine Market Facts & Figures
11.1 India Quadrivalent Flu Vaccine Sales by Company
11.1.1 India Quadrivalent Flu Vaccine Sales by Company (2016-2021)
11.1.2 India Quadrivalent Flu Vaccine Revenue by Company (2016-2021)
11.2 India Quadrivalent Flu Vaccine Sales Breakdown by Type
11.2.1 India Quadrivalent Flu Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Quadrivalent Flu Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Quadrivalent Flu Vaccine Sales Breakdown by Application
11.3.1 India Quadrivalent Flu Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Quadrivalent Flu Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Quadrivalent Flu Vaccine Business
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Corporation Information
12.1.2 Sanofi Pasteur Business Overview
12.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Products Offered
12.1.5 Sanofi Pasteur Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Quadrivalent Flu Vaccine Products Offered
12.2.5 AstraZeneca Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Business Overview
12.3.3 CSL Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Quadrivalent Flu Vaccine Products Offered
12.3.5 CSL Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Business Overview
12.4.3 Abbott Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Quadrivalent Flu Vaccine Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Products Offered
12.5.5 GlaxoSmithKline Recent Development
...
13 Quadrivalent Flu Vaccine Manufacturing Cost Analysis
13.1 Quadrivalent Flu Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Quadrivalent Flu Vaccine
13.4 Quadrivalent Flu Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Quadrivalent Flu Vaccine Distributors List
14.3 Quadrivalent Flu Vaccine Customers
15 Market Dynamics
15.1 Quadrivalent Flu Vaccine Market Trends
15.2 Quadrivalent Flu Vaccine Drivers
15.3 Quadrivalent Flu Vaccine Market Challenges
15.4 Quadrivalent Flu Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
    Table 1. Global Quadrivalent Flu Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Quadrivalent Flu Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Quadrivalent Flu Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Quadrivalent Flu Vaccine Sales (K Doses) by Region (2016-2021)
    Table 5. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2016-2021)
    Table 6. Global Quadrivalent Flu Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Quadrivalent Flu Vaccine Revenue Share by Region (2016-2021)
    Table 8. Global Quadrivalent Flu Vaccine Sales (K Doses) Forecast by Region (2022-2027)
    Table 9. Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Quadrivalent Flu Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Quadrivalent Flu Vaccine Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Quadrivalent Flu Vaccine Sales (K Doses) of Key Companies (2016-2021)
    Table 13. Global Quadrivalent Flu Vaccine Sales Share by Company (2016-2021)
    Table 14. Global Quadrivalent Flu Vaccine Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Quadrivalent Flu Vaccine Revenue Share by Company (2016-2021)
    Table 16. Global Quadrivalent Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Quadrivalent Flu Vaccine as of 2020)
    Table 17. Global Quadrivalent Flu Vaccine Average Price (USD/Dose) of Key Company (2016-2021)
    Table 18. Manufacturers Quadrivalent Flu Vaccine Manufacturing Sites and Area Served
    Table 19. Manufacturers Quadrivalent Flu Vaccine Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Quadrivalent Flu Vaccine Sales (K Doses) by Type (2016-2021)
    Table 22. Global Quadrivalent Flu Vaccine Sales Share by Type (2016-2021)
    Table 23. Global Quadrivalent Flu Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Type (2016-2021)
    Table 25. Global Quadrivalent Flu Vaccine Sales Share by Type (2022-2027)
    Table 26. Global Quadrivalent Flu Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 27. Global Quadrivalent Flu Vaccine Revenue Share by Type (2022-2027)
    Table 28. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Type (2022-2027)
    Table 29. Global Quadrivalent Flu Vaccine Sales (K Doses) by Application (2016-2021)
    Table 30. Global Quadrivalent Flu Vaccine Sales Share by Application (2016-2021)
    Table 31. Global Quadrivalent Flu Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Application (2016-2021)
    Table 33. Global Quadrivalent Flu Vaccine Sales (K Doses) by Application (2022-2027)
    Table 34. Global Quadrivalent Flu Vaccine Sales Share by Application (2022-2027)
    Table 35. Global Quadrivalent Flu Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Quadrivalent Flu Vaccine Revenue Share by Application (2022-2027)
    Table 37. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Application (2022-2027)
    Table 38. North America Quadrivalent Flu Vaccine Sales (K Doses) by Company (2016-2021)
    Table 39. North America Quadrivalent Flu Vaccine Sales Market Share by Company (2016-2021)
    Table 40. North America Quadrivalent Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Quadrivalent Flu Vaccine Revenue Market Share by Company (2016-2021)
    Table 42. North America Quadrivalent Flu Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 43. North America Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2021)
    Table 44. North America Quadrivalent Flu Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 45. North America Quadrivalent Flu Vaccine Sales Market Share by Type (2022-2027)
    Table 46. North America Quadrivalent Flu Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 47. North America Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2021)
    Table 48. North America Quadrivalent Flu Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 49. North America Quadrivalent Flu Vaccine Sales Market Share by Application (2022-2027)
    Table 50. Europe Quadrivalent Flu Vaccine Sales (K Doses) by Company (2016-2021)
    Table 51. Europe Quadrivalent Flu Vaccine Sales Market Share by Company (2016-2021)
    Table 52. Europe Quadrivalent Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Quadrivalent Flu Vaccine Revenue Market Share by Company (2016-2021)
    Table 54. Europe Quadrivalent Flu Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 55. Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2021)
    Table 56. Europe Quadrivalent Flu Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 57. Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2022-2027)
    Table 58. Europe Quadrivalent Flu Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 59. Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2021)
    Table 60. Europe Quadrivalent Flu Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 61. Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2022-2027)
    Table 62. China Quadrivalent Flu Vaccine Sales (K Doses) by Company (2016-2021)
    Table 63. China Quadrivalent Flu Vaccine Sales Market Share by Company (2016-2021)
    Table 64. China Quadrivalent Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Quadrivalent Flu Vaccine Revenue Market Share by Company (2016-2021)
    Table 66. China Quadrivalent Flu Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 67. China Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2021)
    Table 68. China Quadrivalent Flu Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 69. China Quadrivalent Flu Vaccine Sales Market Share by Type (2022-2027)
    Table 70. China Quadrivalent Flu Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 71. China Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2021)
    Table 72. China Quadrivalent Flu Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 73. China Quadrivalent Flu Vaccine Sales Market Share by Application (2022-2027)
    Table 74. Japan Quadrivalent Flu Vaccine Sales (K Doses) by Company (2016-2021)
    Table 75. Japan Quadrivalent Flu Vaccine Sales Market Share by Company (2016-2021)
    Table 76. Japan Quadrivalent Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Quadrivalent Flu Vaccine Revenue Market Share by Company (2016-2021)
    Table 78. Japan Quadrivalent Flu Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 79. Japan Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2021)
    Table 80. Japan Quadrivalent Flu Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 81. Japan Quadrivalent Flu Vaccine Sales Market Share by Type (2022-2027)
    Table 82. Japan Quadrivalent Flu Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 83. Japan Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2021)
    Table 84. Japan Quadrivalent Flu Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 85. Japan Quadrivalent Flu Vaccine Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Quadrivalent Flu Vaccine Sales (K Doses) by Company (2016-2021)
    Table 87. Southeast Asia Quadrivalent Flu Vaccine Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Quadrivalent Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Quadrivalent Flu Vaccine Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Quadrivalent Flu Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 91. Southeast Asia Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Quadrivalent Flu Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 93. Southeast Asia Quadrivalent Flu Vaccine Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Quadrivalent Flu Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 95. Southeast Asia Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Quadrivalent Flu Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 97. Southeast Asia Quadrivalent Flu Vaccine Sales Market Share by Application (2022-2027)
    Table 98. India Quadrivalent Flu Vaccine Sales (K Doses) by Company (2016-2021)
    Table 99. India Quadrivalent Flu Vaccine Sales Market Share by Company (2016-2021)
    Table 100. India Quadrivalent Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Quadrivalent Flu Vaccine Revenue Market Share by Company (2016-2021)
    Table 102. India Quadrivalent Flu Vaccine Sales by Type (2016-2021) & (K Doses)
    Table 103. India Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2021)
    Table 104. India Quadrivalent Flu Vaccine Sales by Type (2022-2027) & (K Doses)
    Table 105. India Quadrivalent Flu Vaccine Sales Market Share by Type (2022-2027)
    Table 106. India Quadrivalent Flu Vaccine Sales by Application (2016-2021) & (K Doses)
    Table 107. India Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2021)
    Table 108. India Quadrivalent Flu Vaccine Sales by Application (2022-2027) & (K Doses)
    Table 109. India Quadrivalent Flu Vaccine Sales Market Share by Application (2022-2027)
    Table 110. Sanofi Pasteur Corporation Information
    Table 111. Sanofi Pasteur Description and Business Overview
    Table 112. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 113. Sanofi Pasteur Quadrivalent Flu Vaccine Product
    Table 114. Sanofi Pasteur Recent Development
    Table 115. AstraZeneca Corporation Information
    Table 116. AstraZeneca Description and Business Overview
    Table 117. AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 118. AstraZeneca Quadrivalent Flu Vaccine Product
    Table 119. AstraZeneca Recent Development
    Table 120. CSL Corporation Information
    Table 121. CSL Description and Business Overview
    Table 122. CSL Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 123. CSL Quadrivalent Flu Vaccine Product
    Table 124. CSL Recent Development
    Table 125. Abbott Corporation Information
    Table 126. Abbott Description and Business Overview
    Table 127. Abbott Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 128. Abbott Quadrivalent Flu Vaccine Product
    Table 129. Abbott Recent Development
    Table 130. GlaxoSmithKline Corporation Information
    Table 131. GlaxoSmithKline Description and Business Overview
    Table 132. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 133. GlaxoSmithKline Quadrivalent Flu Vaccine Product
    Table 134. GlaxoSmithKline Recent Development
    Table 135. Production Base and Market Concentration Rate of Raw Material
    Table 136. Key Suppliers of Raw Materials
    Table 137. Quadrivalent Flu Vaccine Distributors List
    Table 138. Quadrivalent Flu Vaccine Customers List
    Table 139. Quadrivalent Flu Vaccine Market Trends
    Table 140. Quadrivalent Flu Vaccine Market Drivers
    Table 141. Quadrivalent Flu Vaccine Market Challenges
    Table 142. Quadrivalent Flu Vaccine Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Quadrivalent Flu Vaccine Product Picture
    Figure 2. Global Quadrivalent Flu Vaccine Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Quadrivalent Flu Vaccine Sales Market Share by Application in 2021 & 2027
    Figure 6. Hospital Examples
    Figure 7. Clinic Examples
    Figure 8. Public Health Agency Examples
    Figure 9. Other Examples
    Figure 10. Global Quadrivalent Flu Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Quadrivalent Flu Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 12. Global Quadrivalent Flu Vaccine Sales (K Doses) Growth Rate (2016-2027)
    Figure 13. Global Quadrivalent Flu Vaccine Price Trends Growth Rate (2016-2027) (USD/Dose)
    Figure 14. Global Quadrivalent Flu Vaccine Revenue Market Share by Region: 2016 VS 2021
    Figure 15. Global Quadrivalent Flu Vaccine Revenue Market Share by Region: 2021 VS 2027
    Figure 16. North America Quadrivalent Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. North America Quadrivalent Flu Vaccine Sales (K Doses) Growth Rate (2016-2027)
    Figure 18. Europe Quadrivalent Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. Europe Quadrivalent Flu Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 20. China Quadrivalent Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. China Quadrivalent Flu Vaccine Sales (Million USD) and Growth Rate (2016-2027)
    Figure 22. Japan Quadrivalent Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Japan Quadrivalent Flu Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Quadrivalent Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Southeast Asia Quadrivalent Flu Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. India Quadrivalent Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. India Quadrivalent Flu Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 28. Global 5 Largest Quadrivalent Flu Vaccine Players Market Share by Revenue in Quadrivalent Flu Vaccine: 2016 & 2020
    Figure 29. Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 30. Global Quadrivalent Flu Vaccine Revenue Share by Type (2016-2021)
    Figure 31. Global Quadrivalent Flu Vaccine Revenue Growth Rate by Type in 2016 & 2020
    Figure 32. Global Quadrivalent Flu Vaccine Revenue Share by Application (2016-2021)
    Figure 33. Global Quadrivalent Flu Vaccine Revenue Growth Rate by Application in 2016 & 2020
    Figure 34. North America Quadrivalent Flu Vaccine Sales Market Share by Type in 2020
    Figure 35. North America Quadrivalent Flu Vaccine Sales Market Share by Application in 2020
    Figure 36. Europe Quadrivalent Flu Vaccine Sales Market Share by Type in 2020
    Figure 37. Europe Quadrivalent Flu Vaccine Sales Market Share by Application in 2020
    Figure 38. China Quadrivalent Flu Vaccine Sales Market Share by Type in 2020
    Figure 39. China Quadrivalent Flu Vaccine Sales Market Share by Application in 2020
    Figure 40. Japan Quadrivalent Flu Vaccine Sales Market Share by Type in 2020
    Figure 41. Japan Quadrivalent Flu Vaccine Sales Market Share by Application in 2020
    Figure 42. Southeast Asia Quadrivalent Flu Vaccine Sales Market Share by Type in 2020
    Figure 43. Southeast Asia Quadrivalent Flu Vaccine Sales Market Share by Application in 2020
    Figure 44. India Quadrivalent Flu Vaccine Sales Market Share by Type in 2020
    Figure 45. India Quadrivalent Flu Vaccine Sales Market Share by Application in 2020
    Figure 46. Key Raw Materials Price Trend
    Figure 47. Manufacturing Cost Structure of Quadrivalent Flu Vaccine
    Figure 48. Manufacturing Process Analysis of Quadrivalent Flu Vaccine
    Figure 49. Quadrivalent Flu Vaccine Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4000
This license allows only one user to access the PDF.

Electronic (PDF)
$6000
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8000
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Infectious Disease Diagnosis Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10N1843
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnostics Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Othe-2O272
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global HPV Associated Disorder Market Size Status and Forecast 2021 2027
Global HPV Associated Disorder Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-28G2646
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Hepatitis B Treatment Market Size Status and Forecast 2021 2027
Global Hepatitis B Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34S2647
Sun Jul 18 00:00:00 UTC 2021

Add to Cart